Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1017 (24 April), doi:10.1136/bmj.328.7446.1017
EDITOREaton et al report a strong risk relation between schizophrenia and coeliac disease.1 We do not believe that their data support this hypothesis.
They define their case sample as 7997 patients with schizophrenia, in whom they found four cases of coeliac disease. They then include the data on parents' coeliac status (eight cases) in their analysis, and this is potentially misleading. If the parents' data are excluded from the analysis the prevalence of coeliac disease in people with new onset schizophrenia is only 0.5 per 1000, which is the same as in their control group.
Eaton et al describe coeliac disease as rare in Denmark, which was the traditional view. Their sample population dated from 1981-98, when diagnostic testing for coeliac disease advanced. Recent data using endomysial antibody to screen the Danish population suggests a prevalence of 1 in 400, more akin to neighbouring Scandinavian countries.2 Underascertainment of the true prevalence of coeliac disease is therefore a real possibility and a potential confounding factor.
Eugene B Campbell, research registrar
Eugene.Campbell{at}nottingham.ac.uk
Stephen Foley, research registrar
Wolfson Digestive Diseases Centre, University Hospital, Nottingham NG7 2UH
What can you learn from this BMJ paper? Read Leanne Tite's Paper+